Loyal’s Celine Halioua: From Defying Doubters To Pioneering Dog Longevity
When Loyal founder Celine Halioua told people she was building a dog longevity startup, they laughed in her face. Now she's running what could be the largest-ever clinical trial to extend canine lifespans — pursuing FDA approval for multiple drugs to help senior and large dogs live two years longer or more. Celine shares her unusual journey to raising $250 million for a startup that defies easy labels, her Upstart Moment taking her biggest fear head-on, and the example she hopes to set for another generation of women deep tech founders. Chapters: 0:00 Intro to Celine and Loyal 1:42 Celine’s…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.